Nestle Shouldn't Face 3D Facial Injection IP Suit, Judge Says
Nestle may escape accusations that its skin care unit infringed a company's patented technology for teaching professionals how to safely inject Botox and dermal fillers after a Delaware federal judge recommended...To view the full article, register now.
Already a subscriber? Click here to view full article